A PHARMACOKINETICS STUDY OF THE EFFECTS OF GSK2118436 ON WARFARIN, THE EFFECTS OF KETOCONAZOLE AND GEMFIBROZIL ON GSK2118436, AND THE EFFECTS OF REPEAT DOSES OF GSK2118436 IN SUBJECTS WITH BRAF MUTANT SOLID TUMORS: